This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International Europe

Early Registration Deadline:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
12-15 May 2025
Congress Center HamburgHamburg, Germany
Save £1000 Book by 6 Dec
Menu
Book Now

Mr Mark Duerkop
Chief Executive Officer at Novasign, Austria
Speaker

Profile

Dr. Mark Duerkop is co-founder and CEO of Novasign GmbH a spin-off from the University of Natural Resources and Life Sciences in Vienna focusing on accelerating bioprocess development by application of advanced machine learning tools. Within the last years Mark developed a hybrid modeling software with his team that help bioprocess engineers to better understand their processes while additionally reducing the experimental effort to find process optima.

Agenda Sessions

  • Digitalization in Biopharma

    , 11:00
    View Session

  • Accelerating Bioprocess Development: Intensified and Model-Based Design of Experiments for Faster, Cost-Effective Production

    , 13:30
    View Session

  • Smart Workflows: From Planning to Actionable Insights – How Digital Process Twins Drive Decision-Making in Industry 4.0

    , 14:50
    View Session

At this event

Prev
Next
Ms Katharina Bauer
Senior Process Expert DSP Development
Novartis

See Mark at BioProcess International Europe

Save £1000 Book by 6 Dec